Advertisement

Topics

Synapse Biomedical, Inc. Company Profile

19:07 EDT 19th August 2018 | BioPortfolio

Founded in 2002, Synapse Biomedical's mission is to provide life transforming treatments through the commercialization of neurostimulation platforms and build a sustainable enterprise on the foundation of scientific & clinical findings that will provide meaningful value to patients, employees, community, and shareholders. Synapse is headquartered in Oberlin, Ohio and has a European Office in Enghien les Bains, France. For more information please visit www.synapsebiomedical.com.


News Articles [261 Associated News Articles listed on BioPortfolio]

Remake, refill, reuse: Recycling at the synapse revealed

(Okinawa Institute of Science and Technology (OIST) Graduate University) OIST Researchers have shown that the speed of neurotransmitter recycling at the synapse is determined by the refilling speed of...

Engineers Model an Artificial Synapse After the Human Brain

NewsA team of researchers have developed an artificial synapse that does not process information like a digital computer, but rather mimics the analog way the human brain completes tasks.

If Only A.I. Had a Brain—Engineers Model an Artificial Synapse After the Human Brain

NewsResearchers have developed an "artificial synapse" that does not process information like a digital computer but mimics how the human brain completes tasks.

Synapse-specific plasticity governs the identity of overlapping memory traces

(Japan Science and Technology Agency) Each memory is stored in a specific population of neurons called engram cells. When a memory is linked with another to generate an associative memory, two memory ...

Spectrin is a mechanoresponsive protein shaping fusogenic synapse architecture during myoblast fusion

Critical period inhibition of NKCC1 rectifies synapse plasticity in the somatosensory cortex and restores adult tactile response maps in fragile X mice

If Only A.I. Had a Brain

University of Pittsburgh engineers model an artificial synapse after the human brain

Aerie Pharmaceuticals and DSM Biomedical Expand Collaboration Agreement

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with ope...

Drugs and Medications [7 Associated Drugs and Medications listed on BioPortfolio]

Zorbtive [EMD Serono, Inc.]

Zorbtive [somatropin (rDNA origin) for injection]

Fludeoxyglucose [Biomedical Research Foundation of Northwest Louisiana]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f18 [Biomedical Research Foundation of Northwest Louisiana]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Serostim [EMD Serono, Inc.]

Serostim [somatropin (rDNA origin) for injection]

Desipramine hydrochloride [Sandoz Inc]

Desipramine Hydrochloride Tablets, USP

PubMed Articles [415 Associated PubMed Articles listed on BioPortfolio]

Molecular diversity underlying cortical excitatory and inhibitory synapse development.

The complexity and precision of cortical circuitries is achieved during development due to the exquisite diversity of synapse types that is generated in a highly regulated manner. Here, we review the ...

Sestd1 Encodes a Developmentally Dynamic Synapse Protein That Complexes With BCR Rac1-GAP to Regulate Forebrain Dendrite, Spine and Synapse Formation.

Class 4 Semaphorins and Plexin-B receptors regulate GABAergic and glutamatergic synapse development in the mammalian hippocampus.

To understand how proper circuit formation and function is established in the mammalian brain, it is necessary to define the genes and signaling pathways that instruct excitatory and inhibitory synaps...

Rap2 and TNIK control Plexin-dependent tiled synaptic innervation in .

During development, neurons form synapses with their fate-determined targets. While we begin to elucidate the mechanisms by which extracellular ligand-receptor interactions enhance synapse specificity...

Mechanics of antigen extraction in the B cell synapse.

B cell encounter with antigen displayed on antigen-presenting cells leads to B cell immune synapse formation, internalisation of the antigen, and stimulation of antibody responses. The sensitivity wit...

Clinical Trials [113 Associated Clinical Trials listed on BioPortfolio]

How Participants Perceive Biomedical Research in Pulmonology

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

Bigfoot Biomedical Clinical Research Center (CRC) Trial

The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical Research...

Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care

The aim of this study is the establishment of a warehouse physiological data and biomedical signal in intensive care adult patients in acute situations from particular records from the Phi...

Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru

This study will evaluate the effectiveness of community-level behavioral and biomedical interventions, each alone and combined, in reducing sexual risk behavior and HIV/sexually transmitte...

Effectiveness of Pain Neuroscience Education vs Biomedical Education for Patients Undergoing Surgery for Shoulder Pain

BACKGROUND Shoulder pain is the third most common musculoskeletal disorder observed in primary care consultations after low back and neck pain. In the absence of successful outcome followi...

Companies [606 Associated Companies listed on BioPortfolio]

Synapse Biomedical, Inc.

Founded in 2002, Synapse Biomedical's mission is to provide life transforming treatments through the commercialization of neurostimulation platforms and build a sustainable enterp...

Synapse Biomedical Inc.

Synapse Biomedical, headquartered in Oberlin, Ohio, 30 miles west of Cleveland, was founded in 2002 to commercialize the NeuRx(TM) platform for treating a number of respiratory insufficiency condition...

Synapse Biomedical Inc

Synapse Biomedical, in collaboration with University Hospitals of Cleveland and Case Western Reserve University, is currently investigating the applications of the DPS System to people with respirator...

Synapse Wireless, Inc.

Synapse Wireless, Inc. (www.synapse-wireless.com) delivers proven, scalable M2M connectivity solutions designed to revolutionize business. Built on its award-winning SNAP® wire...

Synapse-partnership

Established in 1997 by Managing Director Adam Sherlock to provide technology services exclusively to clients in the pharmaceutical and healthcare industries, The Synapse Partnership Limited operates t...

More Information about "Synapse Biomedical, Inc." on BioPortfolio

We have published hundreds of Synapse Biomedical, Inc. news stories on BioPortfolio along with dozens of Synapse Biomedical, Inc. Clinical Trials and PubMed Articles about Synapse Biomedical, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synapse Biomedical, Inc. Companies in our database. You can also find out about relevant Synapse Biomedical, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record